Step 1
A small amount of blood is drawn at your family doctor‘s office.
Step 2
Our assays quantify the biomarkers.
Step 3
Our algorithm evaluates the entered biomarker values.
Step 4
The results are made easy for the doctor to interpret.
Patent approved
Biomarker and Methods for early diagnosis of Alzheimer´s disease
International publication WO 2015/113995 A1 | European patent Nr. 3102950
Valid in: Austria, Belgium, Switzerland, Czech Republic, Germany, Denmark, Spain, France,
Great Britain,
Hungary, Ireland, Italy, Netherlands, Poland, Sweden, Slovenia, Slovakia | Israel | Russia | China | USA
